ATE219676T1 - Verfahren zum abtöten neoplastischer zellen mittels piperazin-oxiran derivaten - Google Patents

Verfahren zum abtöten neoplastischer zellen mittels piperazin-oxiran derivaten

Info

Publication number
ATE219676T1
ATE219676T1 AT97903981T AT97903981T ATE219676T1 AT E219676 T1 ATE219676 T1 AT E219676T1 AT 97903981 T AT97903981 T AT 97903981T AT 97903981 T AT97903981 T AT 97903981T AT E219676 T1 ATE219676 T1 AT E219676T1
Authority
AT
Austria
Prior art keywords
piperazine
neoplastic cells
oxirane derivatives
killing neoplastic
killing
Prior art date
Application number
AT97903981T
Other languages
English (en)
Inventor
Gabriel F Eilon
John W Jacobs
Original Assignee
Hitachi Chemical Co Ltd
Hitachi Chemical Res Ct Inc
Nippon Chemiphar Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hitachi Chemical Co Ltd, Hitachi Chemical Res Ct Inc, Nippon Chemiphar Co filed Critical Hitachi Chemical Co Ltd
Application granted granted Critical
Publication of ATE219676T1 publication Critical patent/ATE219676T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT97903981T 1996-01-26 1997-01-24 Verfahren zum abtöten neoplastischer zellen mittels piperazin-oxiran derivaten ATE219676T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/592,540 US5733911A (en) 1996-01-26 1996-01-26 Method for inducing death of neoplastic cells using piperazne derivatives
PCT/US1997/001231 WO1997026881A1 (en) 1996-01-26 1997-01-24 Method for inducing death of neoplastic cells using piperazine oxirane derivatives

Publications (1)

Publication Number Publication Date
ATE219676T1 true ATE219676T1 (de) 2002-07-15

Family

ID=24371096

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97903981T ATE219676T1 (de) 1996-01-26 1997-01-24 Verfahren zum abtöten neoplastischer zellen mittels piperazin-oxiran derivaten

Country Status (14)

Country Link
US (3) US5733911A (de)
EP (1) EP0877614B1 (de)
JP (1) JP4117404B2 (de)
KR (1) KR100468271B1 (de)
CN (1) CN1220490C (de)
AR (1) AR005569A1 (de)
AT (1) ATE219676T1 (de)
AU (1) AU731125B2 (de)
CA (1) CA2242657A1 (de)
DE (1) DE69713570T2 (de)
ID (1) ID18975A (de)
TW (1) TW475897B (de)
WO (1) WO1997026881A1 (de)
ZA (1) ZA97676B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0826681B1 (de) * 1995-03-31 2002-10-09 Nippon Chemiphar Co., Ltd. Derivate der epoxybernsteinsäure
US5733911A (en) * 1996-01-26 1998-03-31 Hitachi Chemical Co., Ltd. Method for inducing death of neoplastic cells using piperazne derivatives
EP1342720A3 (de) * 1997-09-04 2004-02-11 Nippon Chemiphar Co., Ltd. Epoxysuccinamid-Derivate
EP1094063A1 (de) * 1999-10-18 2001-04-25 Applied Research Systems ARS Holding N.V. 9-(Piperazinylalkyl)carbazole als Bax-Modulatoren
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
ATE358672T1 (de) * 2000-10-23 2007-04-15 Arizona Biomedical Res Commiss Antitumor verbindungen basierend auf der regulierung von protein prenylation
WO2003044535A1 (en) * 2001-11-22 2003-05-30 Mehmet Ozturk Method, antigen and antibody for distinguishing viable and apoptotic cells
CN112472699A (zh) 2013-07-26 2021-03-12 种族肿瘤学公司 改善比生群及衍生物的治疗益处的组合方法
PL407922A1 (pl) * 2014-04-16 2015-10-26 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością Nowe bisfosfoniany i ich zastosowanie

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55115878A (en) * 1979-02-27 1980-09-06 Taisho Pharmaceut Co Ltd Epoxysuccinic acid derivative
JPS55153778A (en) * 1979-05-17 1980-11-29 Taisho Pharmaceut Co Ltd Epoxysuccinylamino acid derivative
US4474800A (en) * 1980-05-13 1984-10-02 Taisho Pharmaceutical Co., Ltd. Epoxysuccinyl amino acid derivatives
JPS57169478A (en) * 1981-04-10 1982-10-19 Nippon Chemiphar Co Ltd Piperazine derivative
JPS6276A (ja) * 1985-03-26 1987-01-06 Toyo Jozo Co Ltd 酵素阻害性新規物質
JPH0832698B2 (ja) * 1987-05-08 1996-03-29 日本ケミファ株式会社 ピペラジン誘導体
WO1991009851A1 (fr) * 1989-12-27 1991-07-11 Japan Tobacco Inc. Derive d'oxyde de 1,3,2-dioxathiolane
WO1993006143A1 (fr) * 1991-09-19 1993-04-01 Cray Valley Sa Resines de petrole thermiquement stables, leur procede de preparation et leur application a la formulation d'adhesifs thermofusibles
JPH0641067A (ja) * 1992-04-20 1994-02-15 Kitasato Inst:The 新規カルパイン阻害物質ｋｐ−１２４１及びその製造法
DK0603769T3 (da) * 1992-12-25 1999-06-14 Mitsubishi Chem Corp Alfa-aminoketonderivater
US5733911A (en) * 1996-01-26 1998-03-31 Hitachi Chemical Co., Ltd. Method for inducing death of neoplastic cells using piperazne derivatives

Also Published As

Publication number Publication date
AU1840297A (en) 1997-08-20
JP4117404B2 (ja) 2008-07-16
ID18975A (id) 1998-05-28
AU731125B2 (en) 2001-03-22
JP2000505792A (ja) 2000-05-16
EP0877614B1 (de) 2002-06-26
US6054437A (en) 2000-04-25
EP0877614A1 (de) 1998-11-18
US5733911A (en) 1998-03-31
CN1220490C (zh) 2005-09-28
ZA97676B (en) 1997-08-25
CN1212623A (zh) 1999-03-31
DE69713570T2 (de) 2003-01-23
TW475897B (en) 2002-02-11
AR005569A1 (es) 1999-06-23
DE69713570D1 (de) 2002-08-01
CA2242657A1 (en) 1997-07-31
WO1997026881A1 (en) 1997-07-31
KR100468271B1 (ko) 2005-07-05
KR19990082064A (ko) 1999-11-15
US5859013A (en) 1999-01-12

Similar Documents

Publication Publication Date Title
DE69739788D1 (de) Verfahren zum Weiterreichen
ATE210391T1 (de) Verfahren zum expandieren von tabak
DE60013420D1 (de) Verfahren zum ringförmigen abdichten
DE69722961D1 (de) Verfahren zum herstellen von individuell angepassten medizinischen vorrichtungen
DE69939916D1 (de) Verfahren zum Herstellen von Folien-Elektroden
DE69707447D1 (de) Verfahren zum kreppen von tissuepapier
DE69803304D1 (de) Hardwareunterstütztes verfahren zum kontextwechsel
DE59808654D1 (de) Verfahren zum aufbringen definierter betätigungskräfte
DE69838585D1 (de) Vorrichtung zum einbringen eines implantats
DE69711416D1 (de) Verfahren zum herstellen von aethylacetat
DE69836868D1 (de) Vorrichtung zum abtrennen von läsionen
DE69519733D1 (de) Verfahren zum zerkleinern von hydroxypropylmethylcellulose
DE69505885D1 (de) Verfahren zum Sterilisieren
ATE434830T1 (de) Verfahren zum planarisieren
DE69735906D1 (de) Verfahren zum Überkopfschweissen
DE69926436D1 (de) Verfahren zum Entfernen von Leukozyten
DE69717887D1 (de) Verfahren zum Verändern von Messeranordnungen
DE69619231D1 (de) Verfahren zum deinken
DE59805351D1 (de) Verfahren zum herstellen von sägebändern
DE69534698D1 (de) Verfahren und Vorrichtung zum Vermittlen von Zellen
DE59801054D1 (de) Verfahren zum überwachen eines einspritzsystems
ATE219676T1 (de) Verfahren zum abtöten neoplastischer zellen mittels piperazin-oxiran derivaten
DE69726676T2 (de) Verfahren zum Auftauen kryokonservierter Zellen
DE59802360D1 (de) Verfahren zum positionieren von gravierorganen
ATE255820T1 (de) Verfahren zum pelletieren